Skin grafting devices are used in wound care for skin transplantation to replace or regenerate damaged skin grafts. Skin grafting devices aid harvesting grafts of skin and transferring them to wounds or burn sites, reducing pain and operating time. Autologous skin grafting uses skin harvested from the patient’s own body to replace damaged skin. Devices used in autologous grafting include dermatome devices, skin graft meshers, and skin graft expanders. Allogeneic skin grafting uses skin from another human donor and involves procurement, processing, and storage of donated skin before application. The global skin grafting device market is witnessing high demand due to rising adoption of autologous skin grafting over allogeneic grafting and increasing inclination towards minimally invasive grafting procedures.
The global skin grafting device Market is estimated to be valued at US$ 942.3 million in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI.
Rising demand for minimally invasive procedures and inclination towards autologous skin grafting are expected to boost growth of the global skin grafting devices market over the forecast period. Increasing number of burn injuries and road accidents globally have also increased the demand for skin grafting procedures using advanced devices. According to the World Health Organization, road accidents account for approximately 1.3 million deaths annually worldwide. Furthermore, growing elderly population suffering from chronic wounds and increasing cases of skin diseases favor market growth. However, high cost of equipment and stringent regulatory approvals might hamper market growth.
The global skin grafting device market is dominated by the skin substitutes segment which holds around 65% of the total market share. Being able to support fast healing with less scarring, skin substitutes are becoming the preferred option for treatment of burn injuries and other chronic and acute wounds. Due to increasing cases of burn injuries worldwide, the demand for skin substitutes is growing exponentially.
Skin Grafting Device Market Segmentation:
By Product Type
By Graft Thickness
By End user
Ambulatory Surgical Centers
Political: Governments across major countries are focusing on increasing awareness about burn prevention, skin donation and skin grafting procedures which is positively impacting the market growth. Favorable regulations regarding reimbursements are further driving the adoption of advanced skin grafting devices.
Economic: Rising healthcare expenditures, growing geriatric population suffering from chronic conditions and trauma injuries are the key factors augmenting the economic growth of this market.
Social: Increasing awareness about availability of effective skin grafting treatment options and skin banks is encouraging patients to undergo such procedures. Growing preference for minimally invasive surgeries is also propelling the demand.
Technological: Leading players are focusing on development of bioengineered skin substitutes using advanced cell culturing and tissue engineering technologies. Collagen based and biosynthetic skin substitutes with better cosmetic outcomes are gaining popularity.
The global Skin Grafting Device Market Size was valued at US$ 942.3 million in 2023 and is expected to reach over US$ 1.6 billion by 2030 expanding at a CAGR of 7.1% during the forecast period.
Regional analysis: North America region currently dominates the global market and is expected to maintain its dominance in the coming years. This can be attributed to continuous technological advancements and availability of reimbursement facilities in the region. Asia Pacific region is anticipated to witness the fastest growth owing to rising healthcare expenditure, increase in trauma and burn injury cases and growing medical tourism in the developing countries of the region.
Key players: Key players operating in the global skin grafting device market are Avita Medical, Smith & Nephew, MiMedx Group, Organogenesis, Zimmer Biomet, Medtronic, Tissue Regenix, Integra Lifesciences, Anika Therapeutics, Nouvag, AlloSource, Merakris Therapeutics, LLC. The major players are focusing on new product launches and strategic partnerships with hospitals and clinics to strengthen their market position.
1. Source: CoherentMI, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it